Denali Therapeutics

Youtube Subscribe

Open: 21.51 Close: 21.39 Change: -0.12

Stop waiting time to find out about Denali Therapeutics: Our AI summarizes all info about it.

How much time have you spent trying to decide whether investing in Denali Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Denali Therapeutics are: …

Concept Map

Semantic Network

Stock Summary

Denali Therapeutics Inc. discovers and develops therapeutic candidates for neurodegenerative and lysosomal diseases. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate product candidate..

Today's Summary

Denali Therapeutics stock has lost 74% since 2020 primarily due to unfavorable change in price to sales multiple (p/s) The size of the biotechnology industry stood at $1.22 trillion at the end of the year.

Today's News

Denali Therapeutics stock has lost 74% since 2020 primarily due to unfavorable change in price to sales multiple (p/s) The size of the biotechnology industry stood at $1.22 trillion at the end of the year.

Stock Profile

"Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative and lysosomal diseases in the United States and internationally. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease; TAK-594/DNL593, which is in Phase I/II clinical trials for the treatment of frontotemporal dementia-granulin; TAK-920/DNL919, which is in Phase I clinical trials for the treatment of Alzheimer's disease. The company also develops DNL310 that is in Phase I/II clinical trials for the treatment of hunter syndrome; DNL343, which is in phase 1 clinical trial the treatment of amyotrophic lateral sclerosis (ALS); SAR443820/DNL788, which is in phase II clinical trial for the treatment of ALS, multiple sclerosis (MS), and Alzheimer's disease; and SAR443122/DNL758, which is in phase II clinical trial for the treatment of cutaneous lupus erythematosus. It has collaboration agreements with Takeda Pharmaceutical Company, Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, Genzyme Corporation, and Centogene. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California."

Keywords

Are looking for the most relevant information about Denali Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Denali Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Denali Therapeutics are: Denali, Therapeutics, stock, lose, primarily, due, unfavorable, and the most common words in the summary are: therapeutic, nasdaq, biotechnology, inc, unlock, denali, company, . One of the sentences in the summary was: Denali Therapeutics stock has lost 74% since 2020 primarily due to unfavorable change in price to sales multiple (p/s) The size of the biotechnology industry stood at $1.22 trillion at the end of the year.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #nasdaq #biotechnology #inc #unlock #denali #company.

Read more →

Youtube Subscribe

---